Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00854113 · ClinicalTrials.gov registry record · Phase 1
Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers
A Phase 1 study, sponsored by Theracos.
- Completed
- Registry status
- Phase 1
- Development phase
- 78
- Enrollment target
NCT00854113 is a Phase 1 study that has completed, run by Theracos. The registered enrollment target is 78 participants.
The verdict
NCT00854113, a Phase 1 study, has completed, sponsored by Theracos.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 78 participants
- Enrollment target
Study Summary
This study evaluated the safety, tolerability and pharmacokinetics of single or multiple doses of EGT0001474.
Interventions
- DRUG Placebo
- DRUG EGT0001474
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00854113
The ClinicalTrials.gov registry entry for NCT00854113 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Theracos, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00854113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00854113 about?
NCT00854113 is a clinical study titled "Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers". This study evaluated the safety, tolerability and pharmacokinetics of single or multiple doses of EGT0001474.
What is the current status of trial NCT00854113?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 78 participants. The study started on 2009-02. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00854113?
The interventions under investigation include: Placebo (DRUG), EGT0001474 (DRUG).
Who is sponsoring clinical trial NCT00854113?
This trial is sponsored by Theracos, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.